Other
Thereafter
Moderna Thereafter decreased by 10.7% to $679M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.3%, from $757M to $679M.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ1 2021
Last reportedQ1 2026May 1, 2026
Metric ID:
other_lessee_operating_lease_liability_to_be_paid_after__c7b883Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $94M | $94M | $51M | $51M | $51M | $48M | $48M | $869M | $784M | $833M | $841M | $757M | $762M | $760M | $679M |
| QoQ Change | — | +0.0% | -45.7% | +0.0% | +0.0% | -5.9% | +0.0% | >999% | -9.8% | +6.3% | +1.0% | -10.0% | +0.7% | -0.3% | -10.7% |
| YoY Change | — | — | — | -45.7% | -45.7% | -5.9% | -5.9% | >999% | >999% | >999% | -3.2% | -3.4% | -8.5% | -9.6% | -10.3% |
Range$48M – $869M
CAGR+75.9%
Avg YoY Growth+386.2%
Median YoY Growth-5.9%
Current Streak2 quarters decline
Frequently Asked Questions
- What is Moderna's thereafter?
- Moderna (MRNA) reported thereafter of $679M in Q1 2026.
- How has Moderna's thereafter changed year-over-year?
- Moderna's thereafter decreased by 10.3% year-over-year, from $757M to $679M.